These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14765727)

  • 1. Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats.
    Nelson R; Spann D; Elliott D; Brondos A; Vulliet R
    J Vet Intern Med; 2004; 18(1):18-24. PubMed ID: 14765727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral hypoglycemics in cats with diabetes mellitus.
    Palm CA; Feldman EC
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):407-15. PubMed ID: 23522179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin detemir treatment in diabetic cats in a practice setting.
    Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
    J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIDDM in the cat: treatment with the oral hypoglycemic medication, glipizide.
    Ford SL
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):599-615. PubMed ID: 7660535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Mar; 210(6):772-7. PubMed ID: 9074678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of oral metformin in cancer-bearing cats.
    Wypij JM
    Vet Comp Oncol; 2017 Jun; 15(2):345-354. PubMed ID: 26490666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Henley K; Cole C;
    J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of bexagliflozin in cats with poorly regulated diabetes mellitus.
    Benedict SL; Mahony OM; McKee TS; Bergman PJ
    Can J Vet Res; 2022 Jan; 86(1):52-58. PubMed ID: 34975223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the antihyperglycemic agent metformin in cats.
    Michels GM; Boudinot FD; Ferguson DC; Hoenig M
    Am J Vet Res; 1999 Jun; 60(6):738-42. PubMed ID: 10376904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hypoglycemic agents for noninsulin-dependent diabetes mellitus in the cat.
    Greco DS
    Semin Vet Med Surg Small Anim; 1997 Nov; 12(4):259-62. PubMed ID: 10889874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline diabetes mellitus: clinical use of long-acting glargine and detemir.
    Bloom CA; Rand J
    J Feline Med Surg; 2014 Mar; 16(3):205-15. PubMed ID: 24563492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral medications for treating diabetes mellitus in dogs and cats.
    Nelson RW
    J Small Anim Pract; 2000 Nov; 41(11):486-90. PubMed ID: 11105786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
    J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
    Roomp K; Rand J
    J Feline Med Surg; 2012 Aug; 14(8):566-72. PubMed ID: 22553309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
    J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
    Martin GJ; Rand JS
    J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats.
    Nelson RW; Feldman EC; Ford SL; Roemer OP
    J Am Vet Med Assoc; 1993 Sep; 203(6):821-7. PubMed ID: 8226235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.
    Li J; Klemm K; O'Farrell AM; Guler HP; Cherrington JM; Schwartz S; Boyea T
    Curr Med Res Opin; 2010 Aug; 26(8):2003-10. PubMed ID: 20583949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.